| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |